Lachlan Brown

Stock Analyst at William Blair

(2.63)
# 1,959
Out of 5,113 analysts
11
Total ratings
66.67%
Success rate
13.99%
Average return

Stocks Rated by Lachlan Brown

Viridian Therapeutics
Dec 3, 2025
Initiates: Outperform
Price Target: n/a
Current: $33.62
Upside: -
Manhattan Associates
Jun 10, 2025
Downgrades: Neutral
Price Target: $270$200
Current: $161.14
Upside: +24.12%
Harrow
Jun 10, 2025
Initiates: Outperform
Price Target: n/a
Current: $42.59
Upside: -
Kalaris Therapeutics
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $9.45
Upside: -
Ocular Therapeutix
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $10.28
Upside: -
Synopsys
Jan 13, 2025
Initiates: Buy
Price Target: $600
Current: $511.35
Upside: +17.34%
Cadence Design Systems
Jan 13, 2025
Initiates: Buy
Price Target: $350
Current: $320.49
Upside: +9.21%
Apellis Pharmaceuticals
Oct 16, 2024
Initiates: Outperform
Price Target: n/a
Current: $23.07
Upside: -
The Descartes Systems Group
May 14, 2024
Initiates: Neutral
Price Target: $90
Current: $79.78
Upside: +12.81%
SPS Commerce
May 14, 2024
Initiates: Buy
Price Target: $220
Current: $90.18
Upside: +143.96%